Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Restasis for Brittle Nails
NCT00986427Phase 2
Key facts
- Status
- Completed
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Countries
- 1
- Modality
- Peptides, Small Molecules
- Conditions
- brittle nail syndrome (BNS)
01
Overview
Phase 2, randomised, single-blind trial of cyclosporine ophthalmic solution in brittle nail syndrome (BNS). Primary endpoint: Physician's Global Assessment at 24 weeks. Started Jul 2009; status: completed.
02
Design
- Study design
- RandomizedSingle-blind
03
Who it enrols
Adults aged 18-75 with a diagnosis of brittle nails based on surface roughness, lamellar peeling, or longitudinal cracking.
04
Endpoints
Primary
Physician's Global Assessment
Secondary
Quality of Life Related to Nail Disease
Beyond the preview
Go deeper on NCT00986427.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00986427.